Metabolic pathways required for the intracellular survival of Leishmania

Annual Review of Microbiology

Volumn 65, Issue , 2011, Pages 543-561

  McConville, Malcolm J ^a   Naderer, Thomas ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Intracellular pathogens; Leishmaniasis; Macrophage; Phagolysosome; Protozoan parasites; Virulence

Indexed keywords

ACIDIFICATION; CARBON SOURCE; CELL VACUOLE; DENDRITIC CELL; ECOLOGICAL NICHE; HOST CELL; LEISHMANIA; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; LEISHMANIA PIFANOI; MACROPHAGE; MICROBIAL METABOLISM; MUTANT; NEUTROPHIL; NONHUMAN; NUTRIENT CONTENT; PARASITE VIRULENCE; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SURVIVAL;

ANIMALS; CELL SURVIVAL; HUMANS; LEISHMANIA; LEISHMANIASIS; METABOLIC NETWORKS AND PATHWAYS; VIRULENCE;

MAMMALIA; PROTOZOA;

EID: 80053242785     PISSN: 00664227     EISSN: 15453251     Source Type: Book Series    
DOI: 10.1146/annurev-micro-090110-102913     Document Type: Review

References (124)

1. Alcolea PJ, Alonso A, Gómez MJ, Moreno I, Domnguez M, et al. 2010. Transcriptomics throughout the life cycle of Leishmania infantum: high down-regulation rate in the amastigote stage. Int J. Parasitol. 40:1497-516
2. Al-Mutairi MS, Cadalbert LC, McGachy HA, Shweash M, Schroeder J, et al. 2010. MAP kinase phosphatase-2 plays a critical role in response to infection by Leishmania mexicana. PLoS Pathog. 6:e1001192
3. Altmann K, Westermann B. 2005. Role of essential genes in mitochondrial morphogenesis in Saccharomyces cerevisiae. Mol. Biol. Cell 16:5410-17 (Pubitemid 41566849)
4. Antoine JC, Prina E, Courret N, Lang T. 2004. Leishmania spp.: on the interactions they establish with antigen-presenting cells of their mammalian hosts. Adv. Parasitol. 58:1-68 (Pubitemid 39643142)
5. Beattie L, Peltan A, Maroof A, Kirby A, Brown N, et al. 2010. Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells. PLoS Pathog. 6:e1000805
6. Belkaid Y, Mendez S, Lira R, Kadambi N, Milon G, et al. 2000. A natural model of Leishmania major infection reveals a prolonged 'silent? phase of parasite amplification in the skin before the onset of lesion formation and immunity. J. Immunol. 165:969-77 (Pubitemid 30484766)
7. Bern C, Maguire JH, Alvar J. 2008. Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl. Trop. Dis. 2:e313
8. Besteiro S, Williams RA, Coombs GH, Mottram JC. 2007. Protein turnover and differentiation in Leishmania. Int. J. Parasitol. 37:1063-75 (Pubitemid 47042029)
9. Bhardwaj S, Srivastava N, Sudan R, Saha B. 2010. Leishmania interferes with host cell signaling to devise a survival strategy. J. Biomed. Biotechnol. 2010:109189
10. Blum JJ. 1990. Effects of culture age and hexoses on fatty acid oxidation by Leishmania major. J. Protozool. 37:505-10
11. Bocedi A, Dawood KF, FabriniR, Federici G, GradoniL, et al. 2009. Trypanothione efficiently intercepts nitric oxide as a harmless iron complex in trypanosmatid parasites. FASEB J. 24:1035-42
12. Bogdan C, Donhauser N, Doring R, Rollinghoff M, Diefenbach A, et al. 2000. Fibroblasts as host cells in latent leishmaniosis. J. Exp. Med. 191:2121-30
13. Boitz JM, Ullman B. 2010. Amplification of adenine phosphoribosyltransferase suppresses the conditionally lethal growth and virulence phenotype of Leishmania donovani mutants lacking both hypoxanthineguanine and xanthine phosphoribosyltransferases. J. Biol. Chem. 285:18555-64
14. Brauer MJ, Huttenhower C, Airoldi EM, Rosenstein R,Matese JC, et al. 2008. Coordination of growth rate, cell cycle, stress response, and metabolic activity in yeast. Mol. Biol. Cell 19:352-67 (Pubitemid 351186159)
15. Bruhn KW, Marathe C, Maretti-Mira AC, Nguyen H, Haskell J, et al. 2010. LXR deficiency confers increased protection against visceral Leishmania infection in mice. PLoS Negl. Trop. Dis. 4:e886
16. Burchmore RJ, Rodriguez-Contreras D,McBride K, Merkel P, Barrett MP, et al. 2003. Genetic characterization of glucose transporter function in Leishmania mexicana. Proc. Natl. Acad. Sci. USA 100:3901-6 (Pubitemid 36418129)
17. CameronP,McGachyA,AndersonM,PaulA,CoombsGH,et al. 2004. Inhibition of lipopolysaccharideinduced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway. J. Immunol. 173:3297-304 (Pubitemid 39142038)
18. Capul AA, Hickerson S, Barron T, Turco SJ, Beverley SM. 2007. Comparisons of mutants lacking the Golgi UDP-galactose or GDP-mannose transporters establish that phosphoglycans are important for promastigote but not amastigote virulence in Leishmania major. Infect. Immun. 75:4629-37 (Pubitemid 47378124)
19. Carter NS, Yates PA, Gessford SK, Galagan SR, Landfear SM, et al. 2010. Adaptive responses to purine starvation in Leishmania donovani. Mol. Microbiol. 78:92-107
20. Chakraborty D, Banerjee S, Sen A, Banerjee KK, Das P, et al. 2005. Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts. J. Immunol. 175:3214-24 (Pubitemid 41170542)
21. Chavali AK, Whittemore JD, Eddy JA, Williams KT, Papin JA. 2008. Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major. Mol. Syst. Biol. 4:177 (Pubitemid 351441044)
22. Contreras I, Gomez MA, Nguyen O, Shio MT, McMaster RW, et al. 2010. Leishmania-induced inactivation of the macrophage transcription factor AP-1 is mediated by the parasite metalloprotease GP63. PLoS Pathog. 6:e1001148
23. Croft SL, Sundar S, Fairlamb AH. 2006. Drug resistance in leishmaniasis. Clin.Microbiol. Rev. 19:111-26 (Pubitemid 43157649)
24. CunninghamML, Titus RG, Turco SJ, Beverley SM. 2001. Regulation of differentiation to the infective stage of the protozoan parasite Leishmania major by tetrahydrobiopterin. Science 292:285-87 (Pubitemid 32295386)
25. Das P, Lahiri A, Lahiri A, Chakravortty D. 2010. Modulation of the arginase pathway in the context of microbial pathogenesis: a metabolic enzyme moonlighting as an immune modulator. PLoS Pathog. 6:e1000899
26. Davis JM, Ramakrishnan L. 2009. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136:37-49
27. De Trez C, Magez S, Akira S, Ryffel B, Carlier Y, et al. 2009. iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice. PLoS Pathog. 5:e1000494
28. Depledge DP, Evans KJ, Ivens AC, Aziz N, Maroof A, et al. 2009. Comparative expression profiling of Leishmania: modulation in gene expression between species and in different host genetic backgrounds. PLoS Negl. Trop. Dis. 3:e476
29. Dey R, Meneses C, Salotra P, Kamhawi S, Nakhasi HL, et al. 2010. Characterization of a Leishmania stage-specific mitochondrial membrane protein that enhances the activity of cytochrome c oxidase and its role in virulence. Mol. Microbiol. 77:399-414
30. DoyleMA, MacRae JI, De SouzaDP, Saunders EC,McConville MJ, et al. 2009. LeishCyc: a biochemical pathways database for Leishmania major. BMC Syst. Biol. 3:57
31. Dridi L, Ahmed Ouameur A, Ouellette M. 2010. High affinity S-adenosylmethionine plasma membrane transporter of Leishmania is a member of the folate biopterin transporter (FBT) family. J. Biol. Chem. 285:19767-75
32. Dumas C, Ouellette M, Tovar J, Cunningham ML, Fairlamb AH, et al. 1997. Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages. EMBO J. 16:2590-98 (Pubitemid 27226198)
33. Eisenreich W, Dandekar T, Heesemann J,GoebelW. 2010. Carbon metabolism of intracellular bacterial pathogens and possible links to virulence. Nat. Rev. Microbiol. 8:401-12
34. Gagnon E, Duclos S, Rondeau C, Chevet E, Cameron PH, et al. 2002. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110:119-31 (Pubitemid 34874611)
35. Gallardo-Soler A, Gómez-Nieto C, Campo ML, Marathe C, Tontonoz P, et al. 2008. Arginase I induction by modified lipoproteins in macrophages: a peroxisome proliferator-activated receptorgamma/ delta-mediated effect that links lipid metabolism and immunity. Mol. Endocrinol. 22:1394-402
36. Garami A, Ilg T. 2001. Disruption of mannose activation in Leishmania mexicana: GDP-mannose pyrophosphorylase is required for virulence, but not for viability. EMBO J. 20:3657-66 (Pubitemid 32691777)
37. Garami A, Ilg T. 2001. The role of phosphomannose isomerase in Leishmania mexicana glycoconjugate synthesis and virulence. J. Biol. Chem. 276:6566-75
38. Gaur U, Roberts SC, Dalvi RP, Corraliza I, Ullman B, et al. 2007. An effect of parasite-encoded arginase on the outcome of murine cutaneous leishmaniasis. J. Immunol. 179:8446-53
39. Gaur U, Showalter M, Hickerson S, Dalvi R, Turco SJ, et al. 2009. Leishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hosts. Exp. Parasitol. 122:182-91
40. Gueirard P, Laplante A, Rondeau C, Milon G, Desjardins M. 2008. Trafficking of Leishmania donovani promastigotes in non-lytic compartments in neutrophils enables the subsequent transfer of parasites to macrophages. Cell Microbiol. 10:100-11 (Pubitemid 350239059)
41. Hart DT,CoombsGH.1982. Leishmania mexicana: energymetabolism of amastigotes and promastigotes. Exp. Parasitol. 54:397-409 (Pubitemid 13149794)
42. Huynh C, Sacks DL, Andrews NW. 2006. A Leishmania amazonensis ZIP family iron transporter is essential for parasite replication within macrophage phagolysosomes. J. Exp. Med. 203:2363-75 (Pubitemid 44498370)
43. Ilg T. 2002. Generation of myo-inositol-auxotrophic Leishmania mexicana mutants by targeted replacement of the myo-inositol-1-phosphate synthase gene. Mol. Biochem. Parasitol. 120:151-56 (Pubitemid 34159301)
44. Inbar E, Canepa GE, Carrillo C, Glaser F, Suter Grotemeyer M, et al. 2010. Lysine transporters in human trypanosomatid pathogens. Amino Acids. In press
45. Iniesta V, Gomez-Nieto LC, Corraliza I. 2001. The inhibition of arginase by N(omega)-hydroxy-Larginine controls the growth of Leishmania inside macrophages. J. Exp. Med. 193:777-84
46. IvensAC, Peacock CS,Worthey EA,MurphyL,AggarwalG, et al. 2005. The genome of the kinetoplastid parasite, Leishmania major. Science 309:436-24
47. Jaramillo M, GomezMA, Larsson O, ShioMT, Topisirovic I, et al. 2011. Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection. Cell Host Microbe 9:331-41
48. Jiang D, Liang J, Noble PW. 2007. Hyaluronan in tissue injury and repair. Annu. Rev. Cell Dev. Biol. 23:435-61
49. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P. 2003. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9:213-19 (Pubitemid 36227724)
50. JoshiMB, Rogers ME, Shakarian AM, YamageM, Al-Harthi SA, et al. 2005. Molecular characterization, expression, and in vivo analysis of LmexCht1: the chitinase of the human pathogen, Leishmania mexicana. J. Biol. Chem. 280:3847-61 (Pubitemid 40223855)
51. Kima PE. 2007. The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist. Int. J. Parasitol. 37:1087-96 (Pubitemid 47042032)
52. Kropf P, Fuentes JM, Fahnrich E, Arpa L, Herath S, et al. 2005. Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J. 19:1000-2 (Pubitemid 40827731)
53. Kropf P, Herath S, WeberV,ModolellM,Muller I. 2003. Factors influencing Leishmania major infection in IL-4-deficient BALB/c mice. Parasite Immunol. 25:439-47 (Pubitemid 38058021)
54. Lahav T, Sivam D, Volpin H, Ronen M, Tsigankov P, et al. 2011. Multiple levels of gene regulation mediate differentiation of the intracellular pathogen Leishmania. FASEB J. 25:515-25
55. Lamerz AC,Damerow S, Kleczka B,Wiese M, van Zandbergen G, et al. 2010. Deletion of UDP-glucose pyrophosphorylase reveals a UDP-glucose independent UDP-galactose salvage pathway in Leishmania major. Glycobiology 20:872-82
56. Landfear SM, Ullman B, Carter NS, Sanchez MA. 2004. Nucleoside and nucleobase transporters in parasitic protozoa. Eukaryot. Cell 3:245-54 (Pubitemid 38497964)
57. Lippuner C, Paape D, Paterou A, Brand J, Richardson M, et al. 2009. Real-time imaging of Leishmania mexicana-infected early phagosomes: a study using primary macrophages generated from green fluorescent protein-Rab5 transgenic mice. FASEB J. 23:483-91
58. Luque-Ortega JR, van't HofW, Veerman EC, Saugar JM, Rivas L. 2008. Human antimicrobial peptide histatin 5 is a cell-penetrating peptide targeting mitochondrial ATP synthesis in Leishmania. FASEB J. 22:1817-28 (Pubitemid 351811459)
59. Madeira da Silva L, Beverley SM. 2010. Expansion of the target of rapamycin (TOR) kinase family and function in Leishmania shows thatTOR3 is required for acidocalcisome biogenesis and animal infectivity. Proc. Natl. Acad. Sci. USA 107:11965-70
60. Marathe C, Bradley MN, Hong C, Lopez F, Ruiz de Galarreta CM, et al. 2006. The arginase II gene is an anti-inflammatory target of liver X receptor in macrophages. J. Biol. Chem. 281:32197-206 (Pubitemid 46036774)
61. Matte C, Descoteaux A. 2010. Leishmania donovani amastigotes impair gamma interferon-induced STAT1 nuclear translocation by blocking the interaction between STAT1' and importin-α. Infect. Immun. 78:3736-43
62. McCall L, Matlashewski G. 2010. Localization and induction of the A2 virulence factor in Leishmania: evidence that A2 protein is a stress response protein. Mol. Microbiol. 77:518-30
63. McConville MJ, de Souza D, Saunders E, Likic VA, Naderer T. 2007. Living in a phagolysosome; metabolism of Leishmania amastigotes. Trends Parasitol. 23:368-75 (Pubitemid 47069957)
64. McConville MJ, Mullin KA, Ilgoutz SC, Teasdale RD. 2002. Secretory pathway of trypanosomatid parasites. Microbiol. Mol. Biol. Rev. 66:122-54 (Pubitemid 34213971)
65. Michels PA, Bringaud F, Herman M, Hannaert V. 2006. Metabolic functions of glycosomes in trypanosomatids. Biochim. Biophys. Acta 1763:1463-77 (Pubitemid 44880465)
66. Morales MA, Watanabe R, Dacher M, Chafey P, Fortea JO, et al. 2010. Phosphoproteome dynamics reveal heat-shock protein complexes specific to the Leishmania donovani infectious stage. Proc. Natl. Acad. Sci. USA 107:8381-86
67. MoreiraW, Leblanc E, Ouellette M. 2009. The role of reduced pterins in resistance to reactive oxygen and nitrogen intermediates in the protozoan parasite Leishmania. Free Radic. Biol. Med. 46:367-75
68. Mukherjee A, Roy G, Guimond C, Ouellette M. 2009. The α-glutamylcysteine synthetase gene of Leishmania is essential and involved in response to oxidants. Mol. Microbiol. 74:914-27
69. Muleme HM, Reguera RM, Berard A, Azinwi R, Jia P, et al. 2009. Infection with arginase-deficient Leishmania major reveals a parasite number-dependent and cytokine-independent regulation of host cellular arginase activity and disease pathogenesis. J. Immunol. 183:8068-76
70. Muraille E, Gounon P, Cazareth J, Hoebeke J, Lippuner C, et al. 2010. Direct visualization of peptide/ MHC complexes at the surface and in the intracellular compartments of cells infected in vivo by Leishmania major. PLoS Pathog. 6:e1001154
71. Murray HW. 2001. Tissue granuloma structure-function in experimental visceral leishmaniasis. Int. J. Exp. Pathol. 82:249-67 (Pubitemid 34225158)
72. MurrayHW, Berman JD, Davies CR, Saravia NG. 2005. Advances in leishmaniasis. Lancet 366:1561-77 (Pubitemid 41540115)
73. Naderer T, Ellis MA, Sernee MF, De Souza DP, Curtis J, et al. 2006. Virulence of Leishmania major in macrophages and mice requires the gluconeogenic enzyme fructose-1,6-bisphosphatase. Proc. Natl. Acad. Sci. USA 103:5502-7
74. Naderer T, Heng J, McConville MJ. 2010. Evidence that intracellular stages of Leishmania major utilize amino sugars as a major carbon source. PLoS Pathogens 6:e1001245
75. Naderer T, Heng, J, McConville MJ. 2011. Calcineurin is required for Leishmania major stress response pathways and for virulence in the mammalian host. Mol. Microbiol. 80:471-80
76. Naderer T, McConville MJ. 2008. The Leishmania-macrophage interaction: a metabolic perspective. Cell Microbiol. 10:301-8
77. Naderer T, Vince JE,McConville MJ. 2004. Surface determinants of Leishmania parasites and their role in infectivity in the mammalian host. Curr. Mol. Med. 4:649-65 (Pubitemid 39172369)
78. Naderer T, Wee E, McConville MJ. 2008. Role of hexosamine biosynthesis in Leishmania growth and virulence. Mol. Microbiol. 69:858-69 (Pubitemid 352033306)
79. Nare B, GarrawayLA, VickersTJ, Beverley SM.2009. PTR1-dependent synthesis of tetrahydrobiopterin contributes to oxidant susceptibility in the trypanosomatid protozoan parasite Leishmania major. Curr. Genet. 55:287-99
80. Ndjamen B, Kang BH, Hatsuzawa K, Kima PE. 2010. Leishmania parasitophorous vacuoles interact continuously with the host cell's endoplasmic reticulum; parasitophorous vacuoles are hybrid compartments. Cell Microbiol. 12:1480-94
81. Opperdoes FR, Coombs GH. 2007. Metabolism of Leishmania: proven and predicted. Trends Parasitol. 23:149-58 (Pubitemid 46428624)
82. Ortiz D, Valdés R, Sanchez MA, Hayenga J, Elya C, et al. 2010. Purine restriction induces pronounced translational upregulation of the NT1 adenosine/pyrimidine nucleoside transporter in Leishmania major. Mol. Microbiol. 78:108-18
83. Osorio y Fortea J, de La Llave E, Regnault B,Coppee JY, MilonG, et al. 2009. Transcriptional signatures of BALB/c mousemacrophages housingmultiplying Leishmania amazonensis amastigotes. BMC Genomics. 10: 119
84. PaapeD,Lippuner C, SchmidM,AckermannR,Barrios-LlerenaME,et al. 2008. Transgenic, fluorescent Leishmania mexicana allow direct analysis of the proteome of intracellular amastigotes. Mol. Cell Proteomics 7:1688-701
85. Pham NK, Mouriz J, Kima PE. 2005. Leishmania pifanoi amastigotes avoid macrophage production of superoxide by inducing heme degradation. Infect. Immun. 73:8322-33 (Pubitemid 41740323)
86. Qi H, Ji J, WanasenN, Soong L. 2004. Enhanced replication of Leishmania amazonensis amastigotes inα- interferon-stimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis. Infect. Immun. 72:988-95 (Pubitemid 38166680)
87. Queiroz R, Benz C, Fellenberg K, Hoheisel JD, Clayton C. 2009. Transcriptome analysis of differentiating trypanosomes reveals the existence of multiple post-transcriptional regulons. BMC Genomics 10:495
88. Ralton JE,Naderer T, PirainoHL, BashtannykTA, Callaghan JM, et al. 2003. Evidence that intracellular 1-2 mannan is a virulence factor in Leishmania parasites. J. Biol. Chem. 278:40757-63 (Pubitemid 37280892)
89. Reguera RM, Balaña-Fouce R, Showalter M, Hickerson S, Beverley SM. 2009. Leishmania major lacking arginase (ARG) are auxotrophic for polyamines but retain infectivity to susceptible BALB/c mice. Mol. Biochem. Parasitol. 165:48-56
90. RichardD,Leprohon P,Drummelsmith J, Ouellette M. 2004. Growth phase regulation of the main folate transporter of Leishmania infantum and its role in methotrexate resistance. J. Biol. Chem. 279:54494-501 (Pubitemid 40053190)
91. Rochette A, Raymond F, Corbeil J, Ouellette M, Papadopoulou B. 2009. Whole-genome comparative RNA expression profiling of axenic and intracellular amastigote forms of Leishmania infantum. Mol. Biochem. Parasitol. 165:32-47
92. Rogers M, Kropf P, Choi BS,Dillon R, Podinovskaia M, et al. 2009. Proteophosphoglycans regurgitated by Leishmania-infected sand flies target the L-arginine metabolism of host macrophages to promote parasite survival. PLoS Pathog. 5:e1000555
93. Rosenzweig D, Smith D, Opperdoes F, Stern S, Olafson RW, et al. 2008. Retooling Leishmania metabolism: from sand fly gut to human macrophage. FASEB J. 22:590-602 (Pubitemid 351225595)
94. Rub A, Dey R, Jadhav M, Kamat R, Chakkaramakkil S, et al. 2009. Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. Nat. Immunol. 10:273-80
95. Rubin-Bejerano I, Fraser I, Grisafi P, Fink GR. 2003. Phagocytosis by neutrophils induces an amino acid deprivation response in Saccharomyces cerevisiae and Candida albicans. Proc. Natl. Acad. Sci. USA 100:11007-12 (Pubitemid 37140143)
96. Russell DG, Xu S, Chakraborty P. 1992. Intracellular trafficking and the parasitophorous vacuole of Leishmania mexicana-infected macrophages. J. Cell Sci. 103:1193-210 (Pubitemid 23042262)
97. SacksD, AndersonC. 2004. Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice. Immunol. Rev. 201:225-38 (Pubitemid 39318455)
98. SamanovicM,Molina-PortelaMP, Chessler AD, Burleigh BA, Raper J. 2009. Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection. PLoS Pathog. 5:e1000276
99. Saunders EC, Chambers JM, Ng W, Naderer T,NgM, et al. 2011. Isotopologue profiling of Leishmania mexicana promastigotes under glucose replete and starvation conditions. J. Biol. Chem. [Epub ahead of print]
100. Saunders EC, DE Souza DP, Naderer T, SerneeMF, Ralton JE, et al. 2010. Central carbon metabolism of Leishmania parasites. Parasitology 137:1303-13
101. Schröder B, Wrocklage C, Pan C, Jäger R, Kösters B, et al. 2007. Integral and associated lysosomal membrane proteins. Traffic. 8: 1676-86
102. Scott DA, Hickerson SM, VickersTJ, Beverley SM. 2008. The role of the mitochondrial glycine cleavage complex in the metabolism and virulence of the protozoan parasite Leishmania major. J. Biol. Chem. 283:155-65
103. Segawa H, Soares RP, Kawakita M, Beverley SM, Turco SJ. 2005. Reconstitution of GDP-mannose transport activity with purified Leishmania LPG2 protein in liposomes. J. Biol. Chem. 280:2028-35
104. Sernee MF, Ralton JE, Dinev Z, Khairallah GN, O'Hair RA, et al. 2006. Leishmania α-1,2-mannan is assembled on a mannose-cyclic phosphate primer. Proc. Natl. Acad. Sci. USA 103:9458-63 (Pubitemid 43955847)
105. Shaked-Mishan P, Suter-Grotemeyer M, Yoel-Almagor T, Holland N, Zilberstein D, et al. 2006. A novel high-affinity arginine transporter from the human parasitic protozoan Leishmania donovani. Mol. Microbiol. 60:30-38 (Pubitemid 43363285)
106. Shamshiev AT, Ampenberger F, Ernst B, Rohrer L,Marsland BJ, et al. 2007. Dyslipidemia inhibits Tolllike receptor-induced activation ofCD8alpha-negative dendritic cells and protectiveTh1 type immunity. J. Exp. Med. 204:441-52 (Pubitemid 46294558)
107. Silverman JM, Clos J, de'Oliveira CC, Shirvani O, Fang Y, et al. 2010. An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages. J. Cell Sci. 123:842-52
108. Spath GF, Garraway LA, Turco SJ, Beverley SM. 2003. The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proc. Natl. Acad. Sci. USA 100:9536-41 (Pubitemid 37033963)
109. Spath GF, Lye LF, Segawa H, Sacks DL, Turco SJ, et al. 2003. Persistence without pathology in phosphoglycan-deficient Leishmania major. Science 301:1241-43 (Pubitemid 37052214)
110. Steenkamp DJ. 2002. Trypanosomal antioxidants and emerging aspects of redox regulation in the trypanosomatids. Antioxid. Redox. Signal. 4:105-21 (Pubitemid 34260691)
111. Tovar J, Cunningham ML, Smith AC, Croft SL, Fairlamb AH. 1998. Down-regulation of Leishmania donovani trypanothione reductase by heterologous expression of a trans-dominant mutant homologue: effect on parasite intracellular survival. Proc. Natl. Acad. Sci. USA 95:5311-16 (Pubitemid 28208594)
112. Turnock DC, Izquierdo L, Ferguson MA. 2007. The de novo synthesis of GDP-fucose is essential for flagellar adhesion and cell growth in Trypanosoma brucei. J. Biol. Chem. 282:28853-63 (Pubitemid 47606036)
113. Uboldi AD, Lueder FB, Walsh P, Spurck T, McFadden GI, et al. 2006. A mitochondrial protein affects cell morphology, mitochondrial segregation and virulence in Leishmania. Int. J. Parasitol. 36:1499-514 (Pubitemid 44751748)
114. Veras PS, Moulia C, Dauguet C, Tunis CT, Thibon M, et al. 1995. Entry and survival of Leishmania amazonensis amastigotes within phagolysosome-like vacuoles that shelter Coxiella burnetii in Chinese hamster ovary cells. Infect. Immun. 63:3502-6
115. Vickers TJ, Orsomando G, de la Garza RD, Scott DA, Kang SO, et al. 2006. Biochemical and genetic analysis of methylenetetrahydrofolate reductase in Leishmania metabolism and virulence. J. Biol. Chem. 281:38150-58 (Pubitemid 46043306)
116. Vinet AF, Fukuda M, Turco SJ, Descoteaux A. 2009. The Leishmania donovani lipophosphoglycan excludes the vesicular proton-ATPase from phagosomes by impairing the recruitment of synaptotagmin V. PLoS Pathog. 5:e1000628
117. Wanasen N, MacLeod CL, Ellies LG, Soong L. 2007. L-arginine and cationic amino acid transporter 2B regulate growth and survival of Leishmania amazonensis amastigotes in macrophages. Infect. Immun. 75:2802-10 (Pubitemid 46870160)
118. Wiese M. 2007. Leishmania MAP kinases-familiar proteins in an unusual context. Int. J. Parasitol. 37:1053-62 (Pubitemid 47042031)
119. Williams RA, Westrop GD, Coombs GH. 2009. Two pathways for cysteine biosynthesis in Leishmania major. Biochem. J. 420:451-62
120. Wilson J, Huynh C, Kennedy KA,Ward DM, Kaplan J, et al. 2008. Control of parasitophorous vacuole expansion by LYST/Beige restricts the intracellular growth of Leishmania amazonensis. PLoS Pathog. 4:e1000179
121. Wyllie S, Cunningham ML, Fairlamb AH. 2004. Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani. J. Biol. Chem. 279:39925-32 (Pubitemid 39258265)
122. Zhang K, Hsu FF, Scott DA, Docampo R, Turk J, et al. 2005. Leishmania salvage and remodelling of host sphingolipids in amastigote survival and acidocalcisome biogenesis. Mol. Microbiol. 55:1566-78 (Pubitemid 40342080)
123. ZhangO,Wilson MC,XuW,Hsu FF, Turk J, et al. 2009. Degradation of host sphingomyelin is essential for Leishmania virulence. PLoS Pathog. 5:e1000692
124. Zaková A, Panigrahi AK, Uboldi AD, Dalley RA, Handman E, et al. 2008. Structural and functional association of Trypanosoma brucei MIX protein with cytochrome c oxidase complex. Eukaryot. Cell 7:1994-2003